You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In PLOS this week: role for TWIST1 gene expression in vascular disease risk, new Campylobacter species, and more.
Among the study's goals is to identify molecular signatures that can distinguish idiopathic pulmonary fibrosis from interstitial lung disease.
The scientists aim to use single-cell analysis to investigate the role of variation in a gene called ID3 in vascular smooth muscle cells.
University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.
The firm will work with investigators from the University of North Carolina at Chapel Hill and the University of Virginia to validate its AIR system in CRISPR workflows.
Nature News reports on machine learning approaches to detect harmful stretches of DNA.
Funded by a $120M grant, the planned interdisciplinary School of Data Science will dedicate perhaps a quarter of its resources to bioinformatics-related activities.
In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.
Researchers found that methylation alterations affected immune response and lipid metabolism pathways in children whose growth had been stunted.
In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.